Tag: VPAS
High Court dismissed BGMA’s claim on being excluded from VPAS negotiation
The High Court has dismissed the British Generic Manufacturers Association (BGMA)'s claim on being excluded from ongoing negotiations between the government and industry to...
Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform
The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...
BGMA seeks judicial review on being excluded from VPAS negotiation
The British Generic Manufacturers Association (BGMA) has sought a judicial review of the Department of Health and Social Care’s (DHSC) decision to negotiate a new Voluntary...
ABPI urges govt to scrap hike in repayment rate for drugmakers
The Association of the British Pharmaceutical Industry (ABPI) on Thursday (February 2) called for the government to scrap its plans to raise the repayment...
High VPAS tax for 2023 risks more medicines shortages, says BGMA
The British Generic Manufacturers Association (BGMA) has raised concerns over the rise in the VPAS rate for 2023 to 26.5 per cent.
The Department of...
BGMA calls for VPAS exemption for branded generics and biosimilars
The British Generic Medicines Association (BGMA) has called for exemption from the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), an agreement between...